retatrutide weight loss per week Shows 28% in 80 Weeks Retatrutide, a triple agonist, delivered

According to the company, people with obesity and knee osteoarthritis taking retatrutide lost up to 71 pounds on average, or nearly 30% of their baseline weight

Diarrhea was reported across all dose groups but was significantly more frequent and more severe at higher doses

In Ukraine, retatrutide is available under the brands ALLUVI (injector pens) and SYNEDICA (injector pens) with 2-8C cold chain delivery nationwide

Research indicates that stopping or interrupting obesity treatments, particularly weight-loss medications like GLP-1 drugs, frequently results in a rapid regain of lost weight

10.1002/rmb2.12034 Reprod Med Biol

When You Should Not Delay Medical Guidance As I always tell my patients: If something feels wrong, your body is talking to you